AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16287389 — intervention group
Group type: COMPARATOR
Intervention: Traditional behavioral couple therapy
Number of subjects: 134
Study 12415022 — intervention group
Group type: EXPERIMENTAL
Intervention: On-call pediatrician
Number of subjects: 1182
Study 12415022 — intervention group
Group type: COMPARATOR
Intervention: Nurse advice service
Number of subjects: 1182
Study 10084000 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 52
Study 10084000 — intervention group
Group type: COMPARATOR
Intervention: Guedel airway
Number of subjects: 52
Study 8584530 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol 0.2 mg
Number of subjects: 15
Study 8584530 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol 0.2 mg
Number of subjects: 15
Study 8584530 — intervention group
Group type: EXPERIMENTAL
Intervention: salmeterol 0.05 mg
Number of subjects: 15
Study 2245947 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate gel (5 ml, pH 3.8) inserted into the vagina daily for 7 consecutive days, followed by prophylactic treatment 3 days monthly for 6 months
Number of subjects: 42
Study 2245947 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 42
Study 2245947 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate gel
Number of subjects: 42
Study 7354280 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral form and return mailer
Number of subjects: 0
Study 30091495 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified developmental care bundle (environmental modifications, positioning and containment, oxygen supplementation, interaction and approach, cue‐based individual care)
Number of subjects: 14
Study 30091495 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental care
Number of subjects: 14
Study 30091495 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 14
Study 29103415 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises during the second stage of labor
Number of subjects: 250
Study 29103415 — intervention group
Group type: COMPARATOR
Intervention: No breathing exercise training
Number of subjects: 250
Study 26314696 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP
Number of subjects: 52
Study 26314696 — intervention group
Group type: COMPARATOR
Intervention: Low-flow O2
Number of subjects: 52
Study 24576874 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 40
Study 24576874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 21134503 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG‐IUS
Number of subjects: 112
Study 21134503 — intervention group
Group type: COMPARATOR
Intervention: COC
Number of subjects: 112
Study 20003785 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture group
Number of subjects: 61
Study 20003785 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro coagulation group
Number of subjects: 61
Study 20003785 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 61
Study 17531279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin low dose (25 microg/kg)
Number of subjects: 0
Study 17531279 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin standard dose (150 microg/kg)
Number of subjects: 0
Study 17531279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin low dose (25 microg/kg) with second dose after 15 days
Number of subjects: 0
Study 15448664 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 236
Study 15448664 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage CSF (GM-CSF)
Number of subjects: 236
Study 15448664 — intervention group
Group type: COMPARATOR
Intervention: No CSF (Control)
Number of subjects: 236
Study 11157606 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone Position (PP)
Number of subjects: 10
Study 11157606 — intervention group
Group type: COMPARATOR
Intervention: Supine Position (SP)
Number of subjects: 10
Study 9643622 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution containing 80 mg sotalol and 20 mg cisapride
Number of subjects: 7
Study 9643622 — intervention group
Group type: COMPARATOR
Intervention: Sublingual tablet of 80 mg sotalol
Number of subjects: 7
Study 7895388 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms twice a day)
Number of subjects: 88
Study 7895388 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) (200 micrograms twice a day)
Number of subjects: 88
Study 3309131 — intervention group
Group type: EXPERIMENTAL
Intervention: captopril
Number of subjects: 626
Study 3309131 — intervention group
Group type: COMPARATOR
Intervention: methyldopa
Number of subjects: 626
Study 3309131 — intervention group
Group type: COMPARATOR
Intervention: propranolol
Number of subjects: 626
Study 30239676 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and Support (TS) combined with Financial Reimbursement (FR)
Number of subjects: 0
Study 30239676 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and Support (TS) alone
Number of subjects: 0
Study 30239676 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (Control)
Number of subjects: 0
Study 28478850 — intervention group
Group type: EXPERIMENTAL
Intervention: Care bundles with chlorhexidine dressing (experimental group)
Number of subjects: 27
Study 28478850 — intervention group
Group type: COMPARATOR
Intervention: Care bundles with advanced dressings (control group)
Number of subjects: 27
Study 24337899 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS alone at 1 Hz frequency
Number of subjects: 75
Study 24337899 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS alone at 10 Hz frequency
Number of subjects: 75
Study 24337899 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS at 1 Hz frequency combined with paroxetine
Number of subjects: 75
Study 24337899 — intervention group
Group type: EXPERIMENTAL
Intervention: paroxetine alone
Number of subjects: 75
Study 24337899 — intervention group
Group type: COMPARATOR
Intervention: placebo (sham rTMS)
Number of subjects: 75
Study 23905373 — intervention group
Group type: EXPERIMENTAL
Intervention: Buyang Huanwu Decoction (BHD) combined with Aspirin (ASP)
Number of subjects: 84
Study 23905373 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel and Aspirin (ASP)
Number of subjects: 84
Study 21827677 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 14
Study 21827677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 18303109 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported alcohol use in the past year
Number of subjects: 4150
Study 18303109 — intervention group
Group type: COMPARATOR
Intervention: No reported alcohol use in the past year
Number of subjects: 4150
Study 16325846 — intervention group
Group type: EXPERIMENTAL
Intervention: Button-press go/no-go task with varying speed of stimulus presentation
Number of subjects: 120
Study 12913785 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 0
Study 12913785 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux (4 weeks)
Number of subjects: 0
Study 11029516 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet-derived wound healing factor (autologous PDWHF)
Number of subjects: 0
Study 11029516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9360513 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose step-up regimen
Number of subjects: 37
Study 9360513 — intervention group
Group type: COMPARATOR
Intervention: Step-down regimen
Number of subjects: 37
Study 1535121 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 39
Study 1535121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 2981292 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with co-trimoxazole prophylaxis
Number of subjects: 103
Study 2981292 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose chemotherapy without co-trimoxazole prophylaxis
Number of subjects: 103
Study 30557160 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc (MVC)
Number of subjects: 48
Study 30557160 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC + Emtricitabine (FTC)
Number of subjects: 48
Study 30557160 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC + Tenofovir (TFV) disoproxil fumarate
Number of subjects: 48
Study 30557160 — intervention group
Group type: EXPERIMENTAL
Intervention: TFV disoproxil fumarate + FTC
Number of subjects: 48
Study 30557160 — intervention group
Group type: COMPARATOR
Intervention: MVC alone
Number of subjects: 48
Study 29280868 — intervention group
Group type: EXPERIMENTAL
Intervention: Labiaplasty
Number of subjects: 24
Study 29280868 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 24
Study 26166531 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological nursing performed by special nurses before, during and after the surgical procedure
Number of subjects: 70
Study 26166531 — intervention group
Group type: COMPARATOR
Intervention: General knowledge of routine treatment and care (Control)
Number of subjects: 70
Study 23333721 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI group (n = 177)
Number of subjects: 263
Study 23333721 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 86)
Number of subjects: 263
Study 21315844 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 874
Study 21315844 — intervention group
Group type: EXPERIMENTAL
Intervention: KCNH2 mutation
Number of subjects: 874
Study 21315844 — intervention group
Group type: COMPARATOR
Intervention: QTc
Number of subjects: 874
Study 19477803 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief negotiation interviewing (BNI)
Number of subjects: 212
Study 19477803 — intervention group
Group type: COMPARATOR
Intervention: Usual education activities (Control)
Number of subjects: 212
Study 16728967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 50
Study 16728967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15078052 — intervention group
Group type: EXPERIMENTAL
Intervention: SOA randomized within subjects
Number of subjects: 0
Study 15078052 — intervention group
Group type: EXPERIMENTAL
Intervention: SOA blocked within subjects
Number of subjects: 0
Study 15078052 — intervention group
Group type: COMPARATOR
Intervention: SOA manipulated between subjects
Number of subjects: 0
Study 11531758 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiotherapy (RT)
Number of subjects: 0
Study 11531758 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined chemotherapy and RT
Number of subjects: 0
Study 11531758 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 0
Study 8172510 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental straight-leg raising
Number of subjects: 30
Study 8172510 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical straight-leg raising
Number of subjects: 30
Study 8172510 — intervention group
Group type: COMPARATOR
Intervention: Control group of healthy volunteers
Number of subjects: 30
Study 8172510 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with aberrant muscle activity
Number of subjects: 30
Study 8172510 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with comparable electrical activity to controls
Number of subjects: 30
Study 3215626 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 MU rIFN-alpha/m2 body surface 3 times weekly i.m. during 6 months
Number of subjects: 24
Study 3215626 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 MU rIFN-alpha/m2 body surface 3 times weekly i.m. during 6 months
Number of subjects: 24
Study 3215626 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 MU rIFN-alpha/m2 body surface 3 times weekly i.m. during 6 months
Number of subjects: 24
Study 3215626 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 24
Study 29661382 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-Controlled Infusion (TCI)
Number of subjects: 74
Study 29661382 — intervention group
Group type: COMPARATOR
Intervention: Manual Infusion
Number of subjects: 74
Study 28895933 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein intake (HP) group (n = 11) received a dietary plan with 1.2 g·kg‐1·day‐1 of protein
Number of subjects: 23
Study 28895933 — intervention group
Group type: COMPARATOR
Intervention: Normal protein (NP) group (n = 12) ingested 0.8 g·kg‐1·day‐1 of protein (RDA recommendation)
Number of subjects: 23
Study 28895933 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups performed the same resistance training protocol, 3 times a week, for 10 weeks
Number of subjects: 23
Study 25468401 — intervention group
Group type: EXPERIMENTAL
Intervention: BEST program (Internet-based lifestyle intervention)
Number of subjects: 48
Study 25468401 — intervention group
Group type: COMPARATOR
Intervention: Education group (control)
Number of subjects: 48
Study 23234880 — intervention group
Group type: EXPERIMENTAL
Intervention: EHT 0202 (40 and 80 mg bid)
Number of subjects: 60
Study 23234880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22059476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (LdAA) preoperatively (≤320 mg daily)
Number of subjects: 255
Study 22059476 — intervention group
Group type: COMPARATOR
Intervention: No low-dose acetylsalicylic acid (LdAA) preoperatively
Number of subjects: 255
Study 22059476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (LdAA) preoperatively
Number of subjects: 255
Study 22059476 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline cardiovascular and/or cerebrovascular disease
Number of subjects: 255
Study 18279104 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 50‐4798
Number of subjects: 0
Study 18279104 — intervention group
Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 0
Study 16598294 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter alarms set at 80% (low) and 96% (high), goal range 90‐95% (group 1)
Number of subjects: 72
Study 16598294 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter alarms set at 80% (low) and 94% (high), goal range 88 to 94% (group 2)
Number of subjects: 72
Study 14721997 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (resynchronization therapy)
Number of subjects: 25
Study 10763075 — intervention group
Group type: EXPERIMENTAL
Intervention: Shahal membership
Number of subjects: 1608
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant radiotherapy
Number of subjects: 0
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative cisplatin-based chemotherapy alone
Number of subjects: 0
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with radiotherapy
Number of subjects: 0
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy with alkylating agents
Number of subjects: 0
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged adjuvant chemotherapy (busulfan or cytoxan daily for 2 years)
Number of subjects: 0
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with cyclophosphamide doxorubicin-cisplatin (CAP)
Number of subjects: 0
Study 9765759 — intervention group
Group type: EXPERIMENTAL
Intervention: Current chemotherapy regimens
Number of subjects: 0
Study 8498417 — intervention group
Group type: EXPERIMENTAL
Intervention: Companionship from one of three volunteer labor companions
Number of subjects: 189
Study 8498417 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 189
Study 3320136 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-patient teaching programme (twice a week)
Number of subjects: 30
Study 3320136 — intervention group
Group type: COMPARATOR
Intervention: Control group (no family-patient education)
Number of subjects: 30
Study 31793395 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (stent-retriever and/or thromboaspiration)
Number of subjects: 690
Study 31793395 — intervention group
Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 690
Study 29410020 — intervention group
Group type: EXPERIMENTAL
Intervention: Olympus Exera III, 190-C
Number of subjects: 856
Study 29410020 — intervention group
Group type: COMPARATOR
Intervention: Olympus 160/5-C
Number of subjects: 856
Study 27493100 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 250 mg/d
Number of subjects: 126
Study 27493100 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 500 mg/d
Number of subjects: 126
Study 27493100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 25795699 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF; lenograstim) 15 µg/kg body weight daily on days 1-5
Number of subjects: 81
Study 25795699 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF 15 µg/kg body weight daily on days 1-5 followed by leukapheresis, isolation and aliquoting of CD133+ cells, infusion of freshly isolated CD133+ cells immediately and frozen doses at days 30 and 60 (0.2×10(6) cells/kg for each of the three doses)
Number of subjects: 81
Study 25795699 — intervention group
Group type: COMPARATOR
Intervention: Standard conservative management
Number of subjects: 81
Study 23912172 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 39
Study 23912172 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG
Number of subjects: 39
Study 23912172 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic antibodies)
Number of subjects: 39
Study 21929671 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 38
Study 21929671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 18374755 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane cuffed endotracheal tube
Number of subjects: 134
Study 18374755 — intervention group
Group type: COMPARATOR
Intervention: Polyvinyl chloride cuffed endotracheal tube
Number of subjects: 134
Study 16835404 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute resistance exercise (6 sets of 10 repetition maximum squat)
Number of subjects: 74
Study 16835404 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic resistance exercise training (24 weeks)
Number of subjects: 74
Study 16835404 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study 12637901 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA (mandibular anterior repositioning appliance)
Number of subjects: 30
Study 12637901 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA
Number of subjects: 30
Study 11064850 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone, details on dosage and duration not specified
Number of subjects: 0
Study 8630721 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release albuterol tablets (4 mg twice daily, increasing up to 12 mg q 12h)
Number of subjects: 157
Study 8630721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 8161670 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg q.d.s.)
Number of subjects: 40
Study 8161670 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (150 mg b.d.)
Number of subjects: 40
Study 3948141 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (Roferon‐A), 36 X 10(6)U intramuscularly 3 times weekly
Number of subjects: 20
Study 3948141 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (Roferon‐A) in combination with vinblastine, 0.10‐0.15 mg/kg intravenously every 2 to 3 weeks
Number of subjects: 20
Study 3948141 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (Roferon‐A)
Number of subjects: 20
Study 31605929 — intervention group
Group type: COMPARATOR
Intervention: Ctrl (no pigmentation)
Number of subjects: 75
Study 31605929 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush 1× (brushing on 1 application)
Number of subjects: 75
Study 31605929 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush 3× (brushing on 3 applications)
Number of subjects: 75
Study 31605929 — intervention group
Group type: EXPERIMENTAL
Intervention: Immer 2min (immersion for 2 minutes)
Number of subjects: 75
Study 31605929 — intervention group
Group type: EXPERIMENTAL
Intervention: Immer 4min (immersion for 4 minutes)
Number of subjects: 75
Study 30527204 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.8 French ureteral JJ stents (group 1)
Number of subjects: 188
Study 30527204 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 French ureteral JJ stents (group 2)
Number of subjects: 188
Study 30527204 — intervention group
Group type: COMPARATOR
Intervention: No stent insertion (group 3)
Number of subjects: 188
Study 26275686 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine-A 0.05% ophthalmic emulsion
Number of subjects: 30
Study 26275686 — intervention group
Group type: COMPARATOR
Intervention: Carboxymethylcellulose 0.5% (CMC) eye drops
Number of subjects: 30
Study 24901425 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral buckling surgery (SBS) - cerclage + cryopexy + subretinal fluid drainage (SRD) + SF6 or air (n=28 eyes)
Number of subjects: 44
Study 24901425 — intervention group
Group type: COMPARATOR
Intervention: Pars plana vitrectomy (PPV) - PPV + laser photocoagulation + C3F8
Number of subjects: 44
Study 24901425 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SBS and PPV
Number of subjects: 44
Study 24901425 — intervention group
Group type: COMPARATOR
Intervention: Operated eye vs. fellow eye
Number of subjects: 44
Study 22488662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohorts 1 + 2 (n = 68) with standard induction therapy
Number of subjects: 209
Study 22488662 — intervention group
Group type: COMPARATOR
Intervention: Cohort 3 (n = 141) with modified induction therapy (prednisone 40 mg/m(2)/day, short infusion daunorubicin 30 minutes)
Number of subjects: 209
Study 22488662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohorts 1 + 2 (n = 68) among infants ≤90 days of age at diagnosis
Number of subjects: 209
Study 22488662 — intervention group
Group type: COMPARATOR
Intervention: Cohort 3 (n = 141) among infants ≤90 days of age at diagnosis
Number of subjects: 209